Newborn affected by maternal use of anticonvulsants
ICD-10 P04.13 is a billable code used to indicate a diagnosis of newborn affected by maternal use of anticonvulsants.
P04.13 refers to newborns who are affected by the maternal use of anticonvulsants during pregnancy. These medications, while essential for managing maternal seizure disorders, can lead to various complications in the neonate. Common effects include withdrawal symptoms, teratogenic effects, and potential neurodevelopmental issues. Newborns may present with symptoms such as irritability, feeding difficulties, and abnormal muscle tone. The timing and dosage of maternal medication, as well as the specific anticonvulsant used, can influence the severity of the newborn's condition. It is crucial for healthcare providers to monitor these infants closely for signs of withdrawal and other complications, and to provide appropriate interventions. Documentation should include maternal medication history, timing of exposure, and any observed neonatal symptoms to ensure accurate coding and care planning.
Detailed records of maternal medication use, timing of exposure, and neonatal assessment findings.
Neonates presenting with irritability, feeding difficulties, or seizures in the NICU.
Close monitoring for withdrawal symptoms and potential long-term developmental impacts.
Comprehensive history of maternal drug use and ongoing developmental assessments.
Follow-up visits for developmental milestones in children with a history of anticonvulsant exposure.
Consideration of potential neurodevelopmental delays and the need for early intervention services.
Used in conjunction with P04.13 for initial assessment of affected newborns.
Documentation of maternal history and neonatal assessment findings.
Neonatologists should ensure thorough documentation of the newborn's condition and maternal drug history.
Common symptoms include irritability, feeding difficulties, tremors, and abnormal muscle tone. These symptoms may vary based on the specific anticonvulsant used and the timing of exposure.
